Leathart, Julian B. S.
Newcastle University
3 papers on CoChat
Most cited papers
- Verified
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
Liu, Y.-L., Reeves, H. L., Burt, A. D., Tiniakos, D., McPherson, S., Leathart, J. B. S., Allison, M. E. D., Alexander, G. J., Piguet, A.-C., Anty, R., et al. (2014) · Nature Communications
Liver Disease Diagnosis and TreatmentGenetic Associations and Epidemiology
Cited by 623
- Verified
Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
Liu, Y.-L., Patman, G. L., Leathart, J. B. S., Piguet, A.-C., Burt, A. D., Dufour, J.-F., Day, C. P., Daly, A. K., Reeves, H. L., & Anstee, Q. M. (2014) · Journal of Hepatology
Liver Disease Diagnosis and TreatmentHepatocellular Carcinoma Treatment and Prognosis
Cited by 549
- Verified
Genetic Susceptibility to Diclofenac-Induced Hepatotoxicity: Contribution of UGT2B7, CYP2C8, and ABCC2 Genotypes
Daly, A. K., Aithal, G. P., Leathart, J. B. S., Swainsbury, R. A., Dang, T. S., & Day, C. P. (2007) · Gastroenterology
Drug-Induced Hepatotoxicity and ProtectionPharmacogenetics and Drug Metabolism
Cited by 348
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free